Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities    
Net income (loss) $ 38,120 $ 27,166
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Provision for loss on receivables 2,689 8,685
Depreciation and amortization 1,862 1,925
Amortization of financing costs 6,318 5,632
Equity-based compensation 11,478 15,933
Equity method investments (6,355) (12,186)
Non-cash gain on securitization (14,603) (14,952)
(Gain) loss on sale of receivables and investments 1,305 (218)
Changes in receivables held-for-sale 51,538 (51,649)
Changes in accounts payable and accrued expenses (9,733) 3,666
Change in accrued interest on receivables and investments (14,518) (7,334)
Other (2,375) (3,558)
Net cash provided by (used in) operating activities 65,726 (26,890)
Cash flows from investing activities    
Equity method investments (429,944) (136,582)
Equity method investment distributions received 4,203 36,381
Proceeds from sales of equity method investments 0 1,700
Purchases of and investments in receivables (317,805) (264,618)
Principal collections from receivables 74,328 87,799
Proceeds from sales of receivables 7,634 5,047
Purchases of real estate 0 (4,550)
Purchases of investments and securitization assets (12,969) (2,329)
Proceeds from sales of investments and securitization assets 0 7,020
Withdrawal from escrow accounts 0 15,156
Posting of hedge collateral (13,380) 0
Other (473) (574)
Net cash provided by (used in) investing activities (688,406) (255,550)
Cash flows from financing activities    
Proceeds from credit facilities 467,000 100,000
Principal payments on credit facilities (235,000) 0
Principal payments on term loan (4,788) 0
Proceeds from issuance of commercial paper notes 100,000 50,000
Proceeds from issuance of convertible notes 0 200,000
Net proceeds of common stock issuances 357,594 77,974
Payments of dividends and distributions (72,129) (64,930)
Withholdings on employee share vesting (1,433) (3,161)
Payment of financing costs (921) (8,241)
Other (1,768) (2,545)
Net cash provided by (used in) financing activities 598,486 335,568
Increase (decrease) in cash, cash equivalents, and restricted cash (24,194) 53,128
Cash, cash equivalents, and restricted cash at beginning of period 175,972 251,073
Cash, cash equivalents, and restricted cash at end of period 151,778 304,201
Interest paid 68,167 48,402
Supplemental disclosure of non-cash activity    
Residual assets retained from securitization transactions 26,020 14,952
Issuance of common stock from conversion of Convertible Notes 0 7,674
Deconsolidation of non-recourse debt 32,923 0
Deconsolidation of assets pledged for non-recourse debt 31,371 0
Non-recourse debt    
Cash flows from financing activities    
Principal payments on non-recourse debt $ (10,069) $ (13,529)